Kalyan Roy: A Critical Safety Intervention in Transfusion Medicine
Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:
”Irradiation of Blood Components
A Critical Safety Intervention in Transfusion Medicine
Purpose (Why Irradiation is Essential)
Prevents Transfusion-Associated Graft-versus-Host Disease (TA-GVHD) TA-GVHD is: Rare but almost universally fatal Associated withmore than 90% mortality rate Caused by:
Viable donor T-lymphocytes Engraftment in recipient and lead to immune-mediated tissue destruction
Pathophysiology of TA-GVHD Donor immunocompetent T-cells survive in recipient circulation Recipient (often immunocompromised) cannot eliminate these cells Donor T-cells:
Recognize recipient tissues as foreign Initiate cell-mediated immune attack Target organs: Skin Liver Gastrointestinal tract Bone marrow
Mechanism of Irradiation Utilizes: Gamma radiation or X-ray irradiation Action: Causes DNA damage in donor T-lymphocytes Prevents cellular proliferation and clonal expansion Outcome: Eliminates risk of TA-GVHD while preserving RBC/platelet function
What Irradiation Does NOT Do
- Does not sterilize blood products
- Does not replace leukoreduction
- Does not affect ABO/Rh compatibility
- Does not prevent all transfusion-related complications
Indications (Who Requires Irradiated Blood)
High-Risk Groups: Immunocompromised patients: Hematology/Oncology cases
- Chemotherapy recipients
- Hematopoietic Stem Cell Transplant (HSCT)
- patients Congenital immunodeficiency disorders
Special Clinical Situations:
- Intrauterine transfusion (IUT)
- Neonatal exchange transfusion / selected neonatal cases
- Directed donations from first-degree relatives
Key Risk Factor:
HLA similarity leads to reduced immune recognition, which increases the risk of transfusion-associated graft-versus-host disease (TA-GVHD).
Key Considerations in Practice Irradiation should be:
Indication-based, not routine Applied with clinical judgment and protocol adherence
Balance is Critical:
- Overuse: Decreased RBC shelf life increased Potassium leakage (risk of hyperkalemia) Increased storage lesion
- Underuse: Risk of fatal TA-GVHD Irreversible clinical consequences
Blood Bank and Clinical Perspective Not just a technical process leads to a governance decision Requires: Proper patient identification Clear communication between clinician and blood bank Reflects: Precision medicine in transfusion practice
Core Message Irradiation is a silent safeguard in transfusion medicine – often unnoticed, but critical in preventing catastrophic outcomes.
Take-Home Points TA-GVHD is rare but highly fatal and Preventable Irradiation causes targeted T-cell inactivation Right patient selection is a Life-saving decision Improper dose leads to either toxicity or fatal risk.”
Other posts featuring Kalyan Roy on Hemostasis Today.
-
Sep 5, 2026, 19:20Yubrine Moraa Gachemba: BETULA Adds New Evidence for Catheter-Directed Thrombolysis in PE
-
Sep 5, 2026, 19:18John R. Mehall: The Importance of Anticoagulation Management in ECMO
-
Sep 5, 2026, 19:16Thirunavukkarasu Angappan: Why Hemophilia B Still Needs Both Plasma-Derived and Recombinant Factor IX
-
Sep 5, 2026, 19:15Michelle Leona Cecil: Comprehensive Hemophilia Care Doesn’t Begin and End With One Appointment
-
Sep 5, 2026, 19:13Amparo Santamaria: Stem Cells and Hematology – Unlocking a New Frontier in Ovarian Regeneration
-
Sep 5, 2026, 19:10Strengthening the Public Health System for Blood Disorders – Hemophilia Federation of America
-
Sep 5, 2026, 19:08Deidra D. Harris: Supporting Hemophilia of Georgia and the Bleeding Disorders Community
-
Sep 5, 2026, 19:06Katherine Blackwell: Blessed to Have the Opportunity to Speak at the Hemophilia of Indiana Annual Meeting
-
Sep 5, 2026, 19:04Christy V.: What You Need to Know about GI Bleeding and Hemophilia